ORCHID trial

June 21, 2020

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. 

By VUMC News and Communications

April 8, 2020

Study launched to test hydroxychloroquine as treatment for COVID-19

By Craig Boerner